In essence, these different transgenic mouse models highlight the major role of PD-1/PD-L1 axis deregulation in aggressive lymphomas development, but also showed the involvement of this immune checkpoint in the transformation of indolent lymphomas as long as they express PD-L1. Here, PDCD1 is linked to lymphoma.